Clinical Trial Update: The CANabidiol Use for RElief of Short Term Insomnia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating cannabidiol (CBD) for short-term insomnia shows completion of the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia
• Sleep Disturbance

Drugs mentioned

• CANabidiol Use for Relief of Short Term Insomnia (cannabidiol)

Snippet

Sponsor: Bod Australia | Conditions: Sleep Disturbance, Insomnia | Phase 2 | Status: COMPLETED